The Celonic Group is a “Pure Play” Biologics Contract Development Manufacturing Organization (CDMO).
Celonic’s mission is to help its clients, primarily small to large Biotech and Biosimilar Companies, bring life-saving and improving drugs effectively and efficiently to the market.
Celonic is a pioneer in adopting “next generation” bioprocessing technologies such as process intensification and full perfusion lowering the cost of goods per gram to make drugs more accessible to patients.